Gamma-enolase Antibody - ENO2 Neuroendocrine Marker

Gamma-enolase (ENO2) Antibodies for Neuroendocrine and Neuronal Research

Gamma-enolase (ENO2), also known as neuron-specific enolase (NSE), is a glycolytic enzyme predominantly expressed in neurons and neuroendocrine cells. Beyond its metabolic role, it is widely used as a marker of neuronal differentiation and neuroendocrine lineage. Gamma-enolase antibodies are commonly used to detect ENO2 expression in normal tissues and tumors, where its cytoplasmic localization provides insight into cellular identity and differentiation status.

In normal tissues, Gamma-enolase is strongly expressed in central nervous system structures, including cerebellum and cerebral cortex, as well as in neuroendocrine cell populations. In contrast, most non-neural tissues show minimal expression, making ENO2 a useful marker for identifying neuronal and neuroendocrine components.

Applications of Gamma-enolase Antibodies

Gamma-enolase antibodies are used across multiple research applications to evaluate neuronal and neuroendocrine differentiation. In tissue-based analysis such as immunohistochemistry, these antibodies enable visualization of cytoplasmic staining patterns in neurons and neuroendocrine cells within formalin-fixed, paraffin-embedded tissues.

In addition to tissue-based detection, Gamma-enolase antibodies are used in immunodetection assays such as western blot and ELISA to assess ENO2 expression in cell lysates and biological samples. These approaches support both qualitative and quantitative analysis of neuroendocrine markers across different experimental systems.

Gamma-enolase Expression in Normal and Cancer Tissues

Gamma-enolase expression is highly associated with neuronal and neuroendocrine tissues, where it is localized to the cytoplasm of specialized cell populations. This restricted expression pattern supports its use as a lineage marker in tissue-based studies.

In cancer, ENO2 expression is frequently observed in tumors with neuroendocrine differentiation, including neuroendocrine tumors and subsets of carcinomas exhibiting neuroendocrine features. Cytoplasmic staining patterns reflect tumor cell differentiation and can aid in distinguishing neuroendocrine tumors from non-neuroendocrine malignancies.

Tissue Microarray (TMA) Analysis of Gamma-enolase Antibodies

Tissue microarray (TMA) analysis enables large-scale evaluation of ENO2 expression across diverse normal and cancer tissues under standardized conditions. Gamma-enolase antibodies applied to TMA panels allow direct comparison of staining patterns across hundreds of tissue cores, providing a comprehensive overview of neuronal and neuroendocrine marker distribution.

In TMA-based studies, strong staining is consistently observed in neuronal tissues such as cerebellum and cerebral cortex, as well as in neuroendocrine cell populations, while most non-neural tissues remain largely negative. In cancer tissue arrays, variable staining is observed in tumors with neuroendocrine differentiation, supporting its use in comparative tissue profiling and tumor classification.

Explore Gamma-enolase Antibody Products

A range of Gamma-enolase antibody reagents are available to support different research applications, including immunohistochemistry and other immunodetection assays. These antibodies enable reliable detection of ENO2 expression across a variety of sample types and experimental formats.

A selection of Gamma-enolase antibody products is shown below to support a range of research applications.